Ahmed Zaghloul – CEO, October Pharma, Egypt
Ahmed Zaghloul, CEO of October Pharma, stresses the need for better infrastructure for biosimilars in Egypt to stay competitive on a global level. He also highlights October Pharma’s ambitious export…
MINAPHARM ranks among the leading pharmaceutical companies in Egypt and the Middle East. The company maintains one of the broadest quality-products portfolio within the industry. Their longstanding expertise covers a broad spectrum of medicines, ranging from small molecules to extremely complex bioengineered proteins. Minapharm is leading a transition towards high-value biologicals in developing markets, while expanding a robust small-molecule setup in a business model that represents a far departure from existing regional models. In addition to production of life-saving and life-enhancing medicines, MINAPHARM is adopting an international operation platform for biotechnology and cellular engineering. Novel scientific solutions and technologies contribute to the development of products that were unimaginable a decade ago. Scientific excellence and expertise in cellular and bioprocess engineering enable the companies mission to provide not only developed markets, but also emerging markets with significant economic molecules, thus striking the next frontier. MINAPHARM is constantly demonstrating its ability to achieve the balance between Innovation and Affordability, hence, facing the most complex challenges of unmet medical needs in emerging countries.
Contact
El-Bardissi St., 2T Takseem Asmaa Fahmy St., Heliopolis, Cairo – Egypt.
(+202) 2414-3170/1/2/3/4/5
(+202) 2414-3179
Ahmed Zaghloul, CEO of October Pharma, stresses the need for better infrastructure for biosimilars in Egypt to stay competitive on a global level. He also highlights October Pharma’s ambitious export…
Patrick Tete, managing director of Servier Egypt, highlights the cornerstones of his plan to transform the French company’s Egyptian affiliate, discussing its strengths and its place in Servier’s global operations.…
Dr Mohsen Shalaby, President of Nerhadou, explains how he has built Egypt’s leading mineral supplement and nutraceuticals company from scratch within 25 years. He highlights Nerhadou’s innovative solutions and the…
After months of discussion, in December 2017 Egypt’s Parliament approved a new national health insurance law that aims to overcome some of the inherent problems in the current healthcare system…
Janet Heckman, managing director for the southern and eastern Mediterranean region at the European Bank for Reconstruction and Development (EBRD), discusses the main areas of investment for the Bank and…
Marwa Taher, executive director of the Swiss Egyptian Business Association (SEBA), explains how the association is promoting trade relations between the two countries. She also highlights initiatives of both SEBA…
Amir Ghattas, senior director of the MENA cluster at LEO Pharma, highlights how the company is raising awareness for dermatological diseases in Egypt, having adopted a highly patient-centric focus. He…
Rates of tuberculosis (TB) have dropped dramatically in Egypt over the last 30 years, but there is still work to be done, with the country’s Ministry of Health recently announcing…
Emad Graiss, managing director of Merck North East Africa, explains what it takes to successfully steer a company through a period of economic difficulties, while still growing at a fast…
Mohamed Swilam, country manager of Roche Egypt, explains how ensuring access to medicine in Egypt is not only related to pricing challenges, but also to support healthcare systems, improve diagnosis,…
Ahmed Mostafa, country manager of Amgen in Egypt and Iran, explains how the affiliate has been growing by providing end-to-end solutions. He also gives his take on the Egyptian government’s…
Dr Osama Rostom, deputy head of the Pharmaceutical Chamber of the Federation of Egyptian Industries (FEI), explains how the Egyptian healthcare ecosystem has improved during the last three years thanks…
See our Cookie Privacy Policy Here